Investigational Site Number 840052 — Washington D.C., District of Columbia

Investigational Site Number 840052 is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840052 has participated in 1 clinical trials.

Therapeutic areas: Venous Thromboembolism, Cancer.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840052?

Investigational Site Number 840052 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840052 conducted?

Investigational Site Number 840052 has 1 clinical trials on record. Their work covers Venous Thromboembolism, Cancer.

Is Investigational Site Number 840052 accredited by Crixeo Health?

Investigational Site Number 840052 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840052?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.